Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Stock
Stocks
002399
CNE100000P02
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shenzhen S.E.
16/10/2026
|
5-day change | 1st Jan Change | ||
| 9.320 CNY | -0.85% |
|
-4.41% | -20.95% |
| Market Cap | 12.37B 1.85B 1.65B 1.53B 1.39B 2.62B 176B 2.66B 18.39B 7.21B 91.89B 6.95B 6.8B 292B | P/E 2026 * |
18.6x | P/E 2027 * | 15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 10.03B 1.5B 1.33B 1.24B 1.13B 2.12B 143B 2.16B 14.91B 5.84B 74.53B 5.64B 5.52B 237B | EV / Sales 2026 * |
1.96x | EV / Sales 2027 * | 2.38x |
| Free-Float |
14.94% | Yield 2026 * |
0.64% | Yield 2027 * | 0.75% |
| 1 day | -0.85% | ||
| 1 week | -4.41% | ||
| Current month | -5.38% | ||
| 1 month | -0.64% | ||
| 3 months | -7.81% | ||
| 6 months | -18.53% | ||
| Current year | -20.95% |
| 1 week | 9.23 |  | 9.94 |
| 1 month | 9.23 | | 10 |
| Current year | 8.5 | | 12.64 |
| 1 year | 8.5 | | 12.68 |
| 3 years | 6.89 | | 14.34 |
| 5 years | 6.89 | | 18.89 |
| 10 years | 6.89 | | 30.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yu Shan
CEO | Chief Executive Officer | 65 | 21/04/1998 |
Tan Li
PRN | Corporate Officer/Principal | 61 | 21/04/1998 |
Juan Chen
DFI | Director of Finance/CFO | 51 | 21/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Tan Li
BRD | Director/Board Member | 61 | 21/04/1998 |
Li Li
CHM | Chairman | 62 | 21/04/1998 |
Yu Shan
BRD | Director/Board Member | 65 | 21/04/1998 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/23/23 A | Sell | 11,200 | 0.0009% | |||
| 5/26/21 A | Other | Chief Financial Officer | 459,588 | 0.2088% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.85% | -4.41% | -21.08% | -25.62% | 1.86B | |
| +0.43% | +7.48% | +52.08% | +106.34% | 1,116B | |
| +0.90% | -0.36% | +33.68% | +62.93% | 610B | |
| +0.71% | +4.77% | +26.17% | +92.90% | 501B | |
| +0.52% | +2.51% | +73.52% | +40.32% | 358B | |
| -0.13% | +7.51% | +33.47% | +48.68% | 366B | |
| -0.95% | +5.93% | +19.86% | +42.48% | 288B | |
| -1.98% | +4.66% | -1.57% | +13.41% | 261B | |
| -0.35% | +6.15% | +45.46% | +52.23% | 235B | |
| -0.75% | +6.18% | +32.03% | +101.15% | 195B | |
| Average | -0.28% | +4.32% | +29.36% | +53.48% | 393.16B | |
| Weighted average by Cap. | +0.06% | +4.93% | +38.80% | +72.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.1B 763M 679M 631M 574M 1.08B 72.59B 1.1B 7.59B 2.97B 37.93B 2.87B 2.81B 121B | 5.62B 840M 747M 694M 632M 1.19B 79.87B 1.21B 8.35B 3.27B 41.73B 3.16B 3.09B 133B |
| Net income | 731M 109M 97.24M 90.31M 82.22M 155M 10.39B 157M 1.09B 426M 5.43B 411M 402M 17.26B | 874M 131M 116M 108M 98.34M 185M 12.43B 188M 1.3B 509M 6.49B 491M 481M 20.65B |
| Net Debt | -2.34B -350M -311M -289M -263M -494M -33.24B -503M -3.48B -1.36B -17.37B -1.31B -1.29B -55.23B | 1B 150M 134M 124M 113M 212M 14.27B 216M 1.49B 585M 7.46B 564M 552M 23.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | CN¥9.320 | -0.85% | 3,601,520 |
| 15/10/26 | CN¥9.400 | -0.74% | 2,592,000 |
| 14/10/26 | CN¥9.470 | -1.56% | 3,096,540 |
| 13/10/26 | CN¥9.620 | -1.13% | 4,053,160 |
| 12/10/26 | CN¥9.730 | -1.62% | 3,749,140 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 002399 Stock
Select your edition
All financial news and data tailored to specific country editions
